{"id":"https://openalex.org/W2129041705","doi":"https://doi.org/10.1182/blood.v98.5.1326","title":"Rituximab therapy of patients with B-cell chronic lymphocytic leukemia","display_name":"Rituximab therapy of patients with B-cell chronic lymphocytic leukemia","publication_year":2001,"publication_date":"2001-09-01","ids":{"openalex":"https://openalex.org/W2129041705","doi":"https://doi.org/10.1182/blood.v98.5.1326","mag":"2129041705","pmid":"https://pubmed.ncbi.nlm.nih.gov/11520778"},"language":"en","primary_location":{"id":"doi:10.1182/blood.v98.5.1326","doi":"https://doi.org/10.1182/blood.v98.5.1326","is_oa":false,"landing_page_url":"https://doi.org/10.1182/blood.v98.5.1326","pdf_url":null,"source":{"id":"https://openalex.org/S200071133","display_name":"Blood","issn_l":"0006-4971","issn":["0006-4971","1528-0020"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Blood","raw_type":"journal-article"},"volume":null,"type":"article","is_traditional":true,"indexed_in":["crossref","pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5108220229","display_name":"D. Huhn","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I118019719","display_name":"F. Hoffmann-La Roche AG","ror":"https://ror.org/00by1q217","country_code":"CH","type":"company","lineage":["https://openalex.org/I118019719"]},{"id":"https://openalex.org/I223822909","display_name":"Heidelberg University","ror":"https://ror.org/038t36y30","country_code":"DE","type":"education","lineage":["https://openalex.org/I223822909"]},{"id":"https://openalex.org/I25974101","display_name":"University of W\u00fcrzburg","ror":"https://ror.org/00fbnyb24","country_code":"DE","type":"education","lineage":["https://openalex.org/I25974101"]},{"id":"https://openalex.org/I2802619606","display_name":"TUM Klinikum","ror":"https://ror.org/04jc43x05","country_code":"DE","type":"healthcare","lineage":["https://openalex.org/I2802619606","https://openalex.org/I62916508"]},{"id":"https://openalex.org/I39343248","display_name":"Humboldt-Universit\u00e4t zu Berlin","ror":"https://ror.org/01hcx6992","country_code":"DE","type":"education","lineage":["https://openalex.org/I39343248"]},{"id":"https://openalex.org/I4210094361","display_name":"Roche Pharma AG (Germany)","ror":"https://ror.org/00sh68184","country_code":"DE","type":"company","lineage":["https://openalex.org/I118019719","https://openalex.org/I4210094361"]},{"id":"https://openalex.org/I4210122495","display_name":"Asklepios Klinik St. Georg","ror":"https://ror.org/0387raj07","country_code":"DE","type":"healthcare","lineage":["https://openalex.org/I4210122495"]},{"id":"https://openalex.org/I62916508","display_name":"Technical University of Munich","ror":"https://ror.org/02kkvpp62","country_code":"DE","type":"education","lineage":["https://openalex.org/I62916508"]},{"id":"https://openalex.org/I7877124","display_name":"Charit\u00e9 \u2013 Universit\u00e4tsmedizin Berlin","ror":"https://ror.org/001w7jn25","country_code":"DE","type":"healthcare","lineage":["https://openalex.org/I7877124"]},{"id":"https://openalex.org/I8204097","display_name":"Ludwig-Maximilians-Universit\u00e4t M\u00fcnchen","ror":"https://ror.org/05591te55","country_code":"DE","type":"education","lineage":["https://openalex.org/I8204097"]}],"countries":["CH","DE"],"is_corresponding":true,"raw_author_name":"D. Huhn","raw_affiliation_strings":["Department of Medicine/Hematology and Oncology, Charit\u00e9 Campus Virchow-Klinikum, Humboldt Universit\u00e4t Berlin, Germany. dieter.parczany@charite.de","Department of Hematology, Allgemeines Krankenhaus St Georg, Hamburg","Department of Medicine, Klinikum Innenstadt Universita\u0308t Mu\u0308nchen","Department of Medicine, Universita\u0308t Heidelberg","Department of Medicine, Universita\u0308t Wu\u0308rzburg","Department of Medicine/ Hematology and Oncology, Klinikum rechts der Isar, Technische Universita\u0308t Mu\u0308nchen","Department of Medicine/Hematology and Oncology, Universita\u0308tsklinikum Benjamin Franklin, Berlin","From the Department of Medicine/Hematology and Oncology, Charite\u0301 Campus Virchow-Klinikum, Humboldt Universita\u0308t Berlin","Hoffmann-La Roche AG, Grenzach-Wyhlen","Medizinische Klinik III, Klinikum Gro\u03b2hadern, Universita\u0308t Mu\u0308nchen","WISP Research Institute, Langenfeld"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Medicine/Hematology and Oncology, Charit\u00e9 Campus Virchow-Klinikum, Humboldt Universit\u00e4t Berlin, Germany. dieter.parczany@charite.de","institution_ids":["https://openalex.org/I39343248","https://openalex.org/I7877124"]},{"raw_affiliation_string":"Department of Hematology, Allgemeines Krankenhaus St Georg, Hamburg","institution_ids":["https://openalex.org/I4210122495"]},{"raw_affiliation_string":"Department of Medicine, Klinikum Innenstadt Universita\u0308t Mu\u0308nchen","institution_ids":["https://openalex.org/I8204097"]},{"raw_affiliation_string":"Department of Medicine, Universita\u0308t Heidelberg","institution_ids":["https://openalex.org/I223822909"]},{"raw_affiliation_string":"Department of Medicine, Universita\u0308t Wu\u0308rzburg","institution_ids":["https://openalex.org/I25974101"]},{"raw_affiliation_string":"Department of Medicine/ Hematology and Oncology, Klinikum rechts der Isar, Technische Universita\u0308t Mu\u0308nchen","institution_ids":["https://openalex.org/I2802619606","https://openalex.org/I62916508"]},{"raw_affiliation_string":"Department of Medicine/Hematology and Oncology, Universita\u0308tsklinikum Benjamin Franklin, Berlin","institution_ids":[]},{"raw_affiliation_string":"From the Department of Medicine/Hematology and Oncology, Charite\u0301 Campus Virchow-Klinikum, Humboldt Universita\u0308t Berlin","institution_ids":["https://openalex.org/I39343248","https://openalex.org/I7877124"]},{"raw_affiliation_string":"Hoffmann-La Roche AG, Grenzach-Wyhlen","institution_ids":["https://openalex.org/I118019719","https://openalex.org/I4210094361"]},{"raw_affiliation_string":"Medizinische Klinik III, Klinikum Gro\u03b2hadern, Universita\u0308t Mu\u0308nchen","institution_ids":["https://openalex.org/I8204097"]},{"raw_affiliation_string":"WISP Research Institute, Langenfeld","institution_ids":[]}]}],"institutions":[],"countries_distinct_count":2,"institutions_distinct_count":10,"corresponding_author_ids":["https://openalex.org/A5108220229"],"corresponding_institution_ids":["https://openalex.org/I118019719","https://openalex.org/I223822909","https://openalex.org/I25974101","https://openalex.org/I2802619606","https://openalex.org/I39343248","https://openalex.org/I4210094361","https://openalex.org/I4210122495","https://openalex.org/I62916508","https://openalex.org/I7877124","https://openalex.org/I8204097"],"apc_list":{"value":5500,"currency":"USD","value_usd":5500},"apc_paid":null,"fwci":15.1899,"has_fulltext":false,"cited_by_count":353,"citation_normalized_percentile":{"value":0.99457658,"is_in_top_1_percent":true,"is_in_top_10_percent":true},"cited_by_percentile_year":{"min":91,"max":100},"biblio":{"volume":"98","issue":"5","first_page":"1326","last_page":"1331"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T11157","display_name":"Chronic Lymphocytic Leukemia Research","score":1.0,"subfield":{"id":"https://openalex.org/subfields/2720","display_name":"Hematology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T11157","display_name":"Chronic Lymphocytic Leukemia Research","score":1.0,"subfield":{"id":"https://openalex.org/subfields/2720","display_name":"Hematology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10185","display_name":"Lymphoma Diagnosis and Treatment","score":0.0,"subfield":{"id":"https://openalex.org/subfields/2734","display_name":"Pathology and Forensic Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11811","display_name":"Cutaneous lymphoproliferative disorders research","score":0.0,"subfield":{"id":"https://openalex.org/subfields/2708","display_name":"Dermatology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/rituximab","display_name":"rituximab","score":1.0},{"id":"https://openalex.org/keywords/chronic-lymphocytic-leukemia","display_name":"chronic lymphocytic leukemia","score":0.9160000085830688},{"id":"https://openalex.org/keywords/cd20","display_name":"CD20","score":0.9039999842643738},{"id":"https://openalex.org/keywords/chimeric-monoclonal-antibody","display_name":"chimeric monoclonal antibody","score":0.9520000219345093},{"id":"https://openalex.org/keywords/previously-treated-patients","display_name":"previously treated patients","score":0.7820000052452087},{"id":"https://openalex.org/keywords/lymphocyte-count-reduction","display_name":"lymphocyte count reduction","score":0.902999997138977},{"id":"https://openalex.org/keywords/t-cell-subsets","display_name":"T cell subsets","score":0.6990000009536743},{"id":"https://openalex.org/keywords/immunophenotype","display_name":"immunophenotype","score":0.7490000128746033},{"id":"https://openalex.org/keywords/adverse-events","display_name":"adverse events","score":0.6759999990463257},{"id":"https://openalex.org/keywords/duration-of-response","display_name":"duration of response","score":0.48399999737739563}],"concepts":[{"id":"https://openalex.org/C2780653079","wikidata":"https://www.wikidata.org/wiki/Q412323","display_name":"Rituximab","level":3,"score":0.9002617597579956},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.8359351754188538},{"id":"https://openalex.org/C18031839","wikidata":"https://www.wikidata.org/wiki/Q5009796","display_name":"CD20","level":3,"score":0.8047682046890259},{"id":"https://openalex.org/C2777938653","wikidata":"https://www.wikidata.org/wiki/Q1088156","display_name":"Chronic lymphocytic leukemia","level":3,"score":0.7512092590332031},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.584930956363678},{"id":"https://openalex.org/C113067387","wikidata":"https://www.wikidata.org/wiki/Q14912836","display_name":"CD5","level":3,"score":0.5707579851150513},{"id":"https://openalex.org/C90924648","wikidata":"https://www.wikidata.org/wiki/Q120569","display_name":"Gastroenterology","level":1,"score":0.5192371010780334},{"id":"https://openalex.org/C2778714382","wikidata":"https://www.wikidata.org/wiki/Q410656","display_name":"Ofatumumab","level":4,"score":0.48966506123542786},{"id":"https://openalex.org/C2777761686","wikidata":"https://www.wikidata.org/wiki/Q715347","display_name":"Lymphocyte","level":2,"score":0.47823041677474976},{"id":"https://openalex.org/C2778461978","wikidata":"https://www.wikidata.org/wiki/Q29496","display_name":"Leukemia","level":2,"score":0.4711137115955353},{"id":"https://openalex.org/C203014093","wikidata":"https://www.wikidata.org/wiki/Q101929","display_name":"Immunology","level":1,"score":0.4659608006477356},{"id":"https://openalex.org/C197934379","wikidata":"https://www.wikidata.org/wiki/Q2047938","display_name":"Adverse effect","level":2,"score":0.4347476661205292},{"id":"https://openalex.org/C2779338263","wikidata":"https://www.wikidata.org/wiki/Q208414","display_name":"Lymphoma","level":2,"score":0.3798929452896118}],"mesh":[{"descriptor_ui":"D000069283","descriptor_name":"Rituximab","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000293","descriptor_name":"Adolescent","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000328","descriptor_name":"Adult","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000368","descriptor_name":"Aged","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000911","descriptor_name":"Antibodies, Monoclonal","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":false},{"descriptor_ui":"D000911","descriptor_name":"Antibodies, Monoclonal","qualifier_ui":"Q000276","qualifier_name":"immunology","is_major_topic":false},{"descriptor_ui":"D000911","descriptor_name":"Antibodies, Monoclonal","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D000951","descriptor_name":"Antigens, Neoplasm","qualifier_ui":"Q000276","qualifier_name":"immunology","is_major_topic":true},{"descriptor_ui":"D000970","descriptor_name":"Antineoplastic Agents","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":false},{"descriptor_ui":"D000970","descriptor_name":"Antineoplastic Agents","qualifier_ui":"Q000276","qualifier_name":"immunology","is_major_topic":false},{"descriptor_ui":"D000970","descriptor_name":"Antineoplastic Agents","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D002318","descriptor_name":"Cardiovascular Diseases","qualifier_ui":"Q000139","qualifier_name":"chemically induced","is_major_topic":false},{"descriptor_ui":"D005260","descriptor_name":"Female","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D005334","descriptor_name":"Fever","qualifier_ui":"Q000139","qualifier_name":"chemically induced","is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D007167","descriptor_name":"Immunotherapy","qualifier_ui":null,"qualifier_name":null,"is_major_topic":true},{"descriptor_ui":"D007262","descriptor_name":"Infusions, Intravenous","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008224","descriptor_name":"Lymphoma, Follicular","qualifier_ui":"Q000276","qualifier_name":"immunology","is_major_topic":false},{"descriptor_ui":"D008224","descriptor_name":"Lymphoma, Follicular","qualifier_ui":"Q000401","qualifier_name":"mortality","is_major_topic":false},{"descriptor_ui":"D008224","descriptor_name":"Lymphoma, Follicular","qualifier_ui":"Q000628","qualifier_name":"therapy","is_major_topic":true},{"descriptor_ui":"D008297","descriptor_name":"Male","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008875","descriptor_name":"Middle Aged","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D009102","descriptor_name":"Multiple Organ Failure","qualifier_ui":"Q000139","qualifier_name":"chemically induced","is_major_topic":false},{"descriptor_ui":"D012074","descriptor_name":"Remission Induction","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D015993","descriptor_name":"Life Tables","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D016019","descriptor_name":"Survival Analysis","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D016130","descriptor_name":"Immunophenotyping","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D018450","descriptor_name":"Disease Progression","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D018655","descriptor_name":"Lymphocyte Count","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D018951","descriptor_name":"Antigens, CD20","qualifier_ui":"Q000276","qualifier_name":"immunology","is_major_topic":true},{"descriptor_ui":"D058846","descriptor_name":"Antibodies, Monoclonal, Murine-Derived","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false}],"locations_count":3,"locations":[{"id":"doi:10.1182/blood.v98.5.1326","doi":"https://doi.org/10.1182/blood.v98.5.1326","is_oa":false,"landing_page_url":"https://doi.org/10.1182/blood.v98.5.1326","pdf_url":null,"source":{"id":"https://openalex.org/S200071133","display_name":"Blood","issn_l":"0006-4971","issn":["0006-4971","1528-0020"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Blood","raw_type":"journal-article"},{"id":"pmid:11520778","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/11520778","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Blood","raw_type":"Clinical Trial"},{"id":"pmh:oai:CiteSeerX.psu:10.1.1.874.5272","doi":null,"is_oa":false,"landing_page_url":"http://citeseerx.ist.psu.edu/viewdoc/summary?doi=10.1.1.874.5272","pdf_url":null,"source":null,"license":null,"license_id":null,"version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"http://www.bloodjournal.org/content/bloodjournal/98/5/1326.full.pdf?sso-checked%3Dtrue","raw_type":"text"}],"best_oa_location":null,"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being","score":1.0}],"study_designs":[{"id":"https://openalex.org/study-designs/clinical-trial","display_name":"Clinical Trial"}],"awards":[],"funders":[],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":19,"referenced_works":["https://openalex.org/W21149459","https://openalex.org/W60865865","https://openalex.org/W78060682","https://openalex.org/W1540507981","https://openalex.org/W1685882185","https://openalex.org/W1880801097","https://openalex.org/W1910831415","https://openalex.org/W1915689252","https://openalex.org/W1933173754","https://openalex.org/W1945251789","https://openalex.org/W1979300931","https://openalex.org/W1998794275","https://openalex.org/W2069219892","https://openalex.org/W2099314298","https://openalex.org/W2104940816","https://openalex.org/W2107202569","https://openalex.org/W2151735361","https://openalex.org/W2168926834","https://openalex.org/W2343168847"],"related_works":["https://openalex.org/W7096193216","https://openalex.org/W2034168567","https://openalex.org/W2159257554","https://openalex.org/W2000652742","https://openalex.org/W21424034","https://openalex.org/W2121662877","https://openalex.org/W2072620152","https://openalex.org/W2263912307","https://openalex.org/W2017472021","https://openalex.org/W2572974889"],"abstract_inverted_index":{"Rituximab":[0,14],"(IDEC-C2B8)":[1],"is":[2,24,229,237],"a":[3,37,98,101,116,125,148],"chimeric":[4],"antibody":[5],"that":[6,218],"binds":[7],"to":[8,41,252],"the":[9,27,43,57,62,69,75,79,87,107,174,201,210,246],"B-cell":[10],"surface":[11],"antigen":[12],"CD20.":[13],"has":[15,220],"significant":[16],"activity":[17,222],"in":[18,29,49,78,86,134,160,209,223],"follicular":[19],"non-Hodgkin":[20],"lymphomas.":[21],"Much":[22],"less":[23],"known":[25],"about":[26],"effects":[28],"chronic":[30],"lymphocytic":[31],"leukemia":[32],"(CLL).":[33],"We":[34],"have":[35],"initiated":[36],"phase":[38],"II":[39],"trial":[40],"evaluate":[42],"efficacy":[44],"and":[45,74,187,245],"safety":[46],"of":[47,71,83,94,103,127,151,163,177,182,203,235,243],"rituximab":[48,219,236],"patients":[50,84,109,114,167,212,225],"with":[51,130,226,248],"CD20+":[52],"pretreated":[53,224],"CLL.":[54],"To":[55],"avoid":[56],"rituximab-associated":[58],"toxicity,":[59],"we":[60,144],"restricted":[61],"tumor":[63],"cell":[64],"load,":[65],"as":[66],"measured":[67],"by":[68],"number":[70,181],"circulating":[72],"lymphocytes":[73],"spleen":[76],"size,":[77],"first":[80],"2":[81],"cohorts":[82],"included":[85],"study.":[88],"Patients":[89],"received":[90],"4":[91,158],"intravenous":[92],"infusions":[93],"375":[95],"mg/m2":[96],"once":[97],"week":[99],"over":[100],"period":[102],"1":[104,131],"month.":[105],"Of":[106],"28":[108,192],"evaluable":[110],"for":[111,124,155,173],"response,":[112],"7":[113],"showed":[115],"partial":[117],"remission":[118,135],"(National":[119],"Cancer":[120],"Institute":[121],"criteria)":[122],"lasting":[123,154],"median":[126],"20":[128],"weeks,":[129],"patient":[132],"still":[133],"after":[136,193,233],"71":[137],"weeks.":[138],"Based":[139],"on":[140],"lymphocyte":[141,152,178],"counts":[142,153,196],"only,":[143],"found":[145],"at":[146,156],"least":[147,157],"50%":[149],"reduction":[150],"weeks":[159],"13":[161],"(45%)":[162],"29":[164],"patients.":[165],"Fifteen":[166],"from":[168],"3":[169],"institutions":[170],"were":[171,197,213],"monitored":[172],"immunophenotype":[175],"profile":[176],"subsets.":[179],"The":[180,215],"CD5+CD20+":[183],"cells":[184],"decreased":[185],"significantly":[186],"remained":[188],"low":[189],"until":[190],"day":[191],"therapy.":[194],"T-cell":[195],"not":[198],"affected.":[199],"With":[200],"exception":[202],"one":[204],"rituximab-related":[205],"death,":[206],"adverse":[207],"events":[208],"remaining":[211],"mild.":[214],"results":[216],"suggest":[217],"clinical":[221],"B-CLL.":[227],"Toxicity":[228],"tolerable.":[230],"Response":[231],"duration":[232],"withdrawal":[234],"rather":[238],"short.":[239],"Therefore,":[240],"other":[241,249],"modes":[242],"application":[244],"combination":[247],"agents":[250],"need":[251],"be":[253],"tested.":[254]},"counts_by_year":[{"year":2026,"cited_by_count":1},{"year":2025,"cited_by_count":2},{"year":2024,"cited_by_count":7},{"year":2023,"cited_by_count":4},{"year":2022,"cited_by_count":2},{"year":2021,"cited_by_count":3},{"year":2020,"cited_by_count":5},{"year":2019,"cited_by_count":7},{"year":2018,"cited_by_count":9},{"year":2017,"cited_by_count":8},{"year":2016,"cited_by_count":6},{"year":2015,"cited_by_count":15},{"year":2014,"cited_by_count":13},{"year":2013,"cited_by_count":14},{"year":2012,"cited_by_count":11}],"updated_date":"2026-11-07T11:25:07.637180","created_date":"2016-06-24T00:00:00"}